Prothena Corp Public PRTA
NASDAQ PRTA
$9.78 +0.18 (+1.93%)
As of: Sep 4, 2026 · 2:36 PM EDT

Prothena Corp Public (PRTA) Other Accumulated Expenses (2012 - 2026)

Prothena Corp Public (PRTA) posted quarterly Other Accumulated Expenses of $10.5 million for Q1 2026, up 13.8% year-over-year from $9.2 million in Q1 2025, and down 10.92% quarter-over-quarter from $11.8 million in Q4 2025.

Analysis

Prothena Corp Public (PRTA) Other Accumulated Expenses (2012 - 2026) Analysis & Trends

Prothena Corp Public's Other Accumulated Expenses history runs 15 years deep, the most recent figure standing at $10.5 million for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses rose 13.8% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $10.5 million (up 13.8% YoY), while the FY2025 annual figure was $11.8 million, down 25.61% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $10.5 million, down from $11.8 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $15.8 million in Q4 2024, with the low at $5.0 million in Q1 2022.
  • The 5-year median for Other Accumulated Expenses is $10.5 million (2026), against an average of $10.7 million.
  • The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses jumped 78.73% in 2022, then tumbled 42.61% in 2025.
  • Prothena Corp Public's Other Accumulated Expenses stood at $12.2 million in 2022, then gained by 28.71% to $15.7 million in 2023, then increased by 1.16% to $15.8 million in 2024, then dropped by 25.61% to $11.8 million in 2025, then dropped by 10.92% to $10.5 million in 2026.
  • Business Quant data shows PRTA's Other Accumulated Expenses at $10.5 million in Q1 2026, $11.8 million in Q4 2025, and $8.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Prothena Corp Public 509.98 Mn 221.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.24 Mn
Mar 31, 2026 10.50 Mn
Dec 31, 2025 11.79 Mn
Sep 30, 2025 8.21 Mn
Jun 30, 2025 6.40 Mn
Mar 31, 2025 9.23 Mn
Dec 31, 2024 15.84 Mn
Sep 30, 2024 14.31 Mn
Jun 30, 2024 10.93 Mn
Mar 31, 2024 9.13 Mn
Dec 31, 2023 15.66 Mn
Sep 30, 2023 13.78 Mn
Jun 30, 2023 10.22 Mn
Mar 31, 2023 8.00 Mn
Dec 31, 2022 12.17 Mn
Sep 30, 2022 13.17 Mn
Jun 30, 2022 7.15 Mn
Mar 31, 2022 4.96 Mn
Dec 31, 2021 9.81 Mn
Sep 30, 2021 7.37 Mn